HPV vaccine cutting cervical cancer rates by 87%
November 4, 2021Business Services
The human papillomavirus (HPV) vaccine is cutting cervical cancer rates by 87% in women who were offered the vaccine between …
HMNC Brain Health appoints Dr Katarina Jelic Maiboe Head of Regulatory Affairs
November 3, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HMNC Brain Health, appointments
HMNC Brain Health, a clinical-stage biopharma company pioneering the development of personalised therapies powered by predictive companion diagnostics, today announced …
Study reveals Alzheimer’s spreads differently than previously thought
November 3, 2021Research and Development
A University of Cambridge research team has used human data to quantify the speed of different processes that lead to …
Clinical trial shows promise for aggressive eye cancer treatment
November 3, 2021Research and Development
A clinical trial with University of Liverpool researchers at The Clatterbridge Cancer Centre has shown great promise for an immunotherapy …
Outsourcing in clinical trials: A response to rising challenges
November 3, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The pandemic has undoubtedly had a detrimental impact on the pharmaceutical and healthcare industries. Brexit has rubbed salt in the …
Risking it all after the pandemic: How companies can pick up the slack post-COVID-19
November 3, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Pharmaceutical manufacturers have always been tasked with some of the most complex remits in the industry. Active pharmaceutical ingredients, potent …
Breakthrough status given to Renew Bioscience’s Alzheimer’s treatment
November 3, 2021Research and Development
Renew Bioscience announced it has received Breakthrough Device Designation status from the FDA for the Cerezen® Device, a novel treatment …
Covid jabs more effective than virus at preventing infection
November 3, 2021Research and Development
A US study has revealed that the immunity received from COVID-19 vaccines is much stronger than that stimulated by infection …
Beverley Carr appointed Chief Business Officer for Amphista Therapeutics
November 2, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing amphista, appointments
Amphista Therapeutics have appointed Beverley Carr Chief Business Officer. Amphista is a leader in next generation targeted protein degradation (TPD) …
Mogrify appoint Tom Graney Non-Executive Director, Audit Chair and Capital Markets Advisor
November 2, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, mogrify
Mogrify Limited have announced the appointment of Tom Graney, CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. He …
BioNet and BIA Separations collaborate on development of mRNA vaccines
November 2, 2021Manufacturing and Production
BioNet, a leading biotech company manufacturing genetically engineered vaccines, and Sartorius’ company BIA Separations, have announced the development of an …
Transplant patients to have mandatory full COVID vaccinations at London Health Sciences Centre
November 2, 2021Manufacturing and Production
The Ontario-based London Health Sciences Centre’s transplant program is implementing a full COVID-19 vaccination requirement for future organ transplant recipients …
Dunad Therapeutics and Novartis enter partnership to develop protein therapies
November 2, 2021Manufacturing and Production
Biopharmaceutical company Dunad Therapeutics (Dunad) has annouced that it has entered into a strategic collaboration with Novartis, to develop orally …
FDA approve Novartis’ Scemblix to treat leukaemia
November 2, 2021Manufacturing and Production
Novartis have announced that the FDA approved Scemblix® (asciminib) for the treatment of chronic myeloid leukaemia (CML) in two distinct …
Skin patch COVID vaccine may prove more effective than injections
November 1, 2021Sales and Marketing
A COVID vaccine skin patch is on course for its first human trial by the University of Queensland in partnership …
China says US COVID origins report lacks credibility
November 1, 2021Sales and Marketing
A US intelligence report saying it was plausible that COVID-19 originated in a Wuhan laboratory has been deemed unscientific and …
FDA issue Pfizer vaccine emergency clearance for children, and delay Moderna
November 1, 2021Sales and Marketing
The FDA has informed Moderna that it needs more time to review the company’s COVID vaccine in children aged 12 …
Study reveals high efficacy of Sputnik V in protecting aged 60+ against COVID
November 1, 2021Sales and Marketing
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) has announced the results of a real world study by …
Gilead collaborate with Merck for first-line triple negative breast cancer trial
October 29, 2021Medical Communications
Gilead Sciences announced that it has entered into a clinical trial collaboration and supply agreement with MSD (known as Merck …
Fluvoxamine effective in reducing hospitalisation in COVID-19 patients
October 29, 2021Medical Communications
A Brazilian study has assessed the effect of early treatment with fluvoxamine on the risk of emergency care and hospitalisation …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
